KRT18 and metabolic dysfunction-associated steatohepatitis: With this awareness, Xiang Zhang et al. proposed a group of three parameters (adjusted body mass index [BMI], C-X-C motif chemokine ligand 10 [CXCL10], and cytokeratin 18 fragments M30 [CK-18]) that allowed patients with MASH to be identified among those with MASLD, achieving 90.0% specificity.